Androgen-dependent somatotroph function in a hypogonadal adolescent male: evidence for control of exogenous androgens on growth hormone release
A 14(10/12)-year-old white male with primary gonadal failure following testicular irradiation for acute lymphocytic leukemia was evaluated for poor growth. He had received 2400 rad of prophylactic cranial irradiation. The growth velocity had decelerated from 7 to 3.2 cm/yr over 3 years. His bone age was 12(0/12) years (by TW2-RUS), and his peak growth hormone (GH) response to provocative stimuli was 1.4 ng/mL. The 24-hour GH secretion was studied by drawing blood every 20 minutes for 24 hours. The resulting GH profile was analyzed by a computerized pulse detection algorithm, CLUSTER. Timed serum GH samples were also obtained after a 1 microgram/kg IV bolus injection of the GH releasing factor (GRH). The studies showed a flat 24-hour profile and a peak GH response to GRH of 3.9 ng/ml. Testosterone enanthate treatment was started, 100 mg IM every 4 weeks. Ten months after the initiation of therapy the calculated growth rate was 8.6 cm/yr. The 24-hour GH study and GRH responses were repeated at the time, showing a remarkably normal 24-hour GH secretory pattern and a peak GH response to GRH of 14.4 ng/mL. Testosterone therapy was discontinued, and 4 months later similar studies were repeated. A marked decrease in the mean 24-hour GH secretion and mean peak height occurred, but with maintenance of the GH pulse frequency. The GH response to GRH was intermediate, with a peak of 8 ng/mL. There was no further growth during those 4 months despite open epiphyses.
- Research Organization:
- Univ. of Virginia Medical Center, Charlottesville (USA)
- OSTI ID:
- 6276202
- Journal Information:
- Metab., Clin. Exp.; (United States), Vol. 38:3
- Country of Publication:
- United States
- Language:
- English
Similar Records
A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom)
Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia
Related Subjects
ANIMAL GROWTH
STIMULATION
LEUKEMIA
RADIOTHERAPY
SIDE EFFECTS
STH
SECRETION
ADOLESCENTS
ALGORITHMS
GROWTH FACTORS
MALES
PITUITARY GLAND
TESTES
TESTOSTERONE
AGE GROUPS
ANDROGENS
ANDROSTANES
BODY
DISEASES
ENDOCRINE GLANDS
GLANDS
GONADS
GROWTH
HEMIC DISEASES
HORMONES
HYDROXY COMPOUNDS
IMMUNE SYSTEM DISEASES
KETONES
MALE GENITALS
MATHEMATICAL LOGIC
MEDICINE
MITOGENS
NEOPLASMS
NUCLEAR MEDICINE
ORGANIC COMPOUNDS
ORGANS
PEPTIDE HORMONES
PITUITARY HORMONES
PROTEINS
RADIOLOGY
STEROID HORMONES
STEROIDS
THERAPY
560151* - Radiation Effects on Animals- Man